Bumper Offer - Urjas oil Just @ Rs. 1
Uridip 300 Tablet is a prescription medicine that is available as a Tablet. It is primarily used for the treatment of Gout, High Uric Acid Levels in the Blood. Secondary and off-label uses of Uridip 300 Tablet have also been mentioned below.
The optimal dosage of Uridip 300 Tablet is largely dependent on the individual's body weight, medical history, gender and age. Individual symptoms and route of administration also determines the right dosage. Refer to the dosage section for a detailed discussion.
While these are the most often observed Uridip 300 Tablet side effects, there are can be others also. These have been listed below. These side effects of Uridip 300 Tablet are usually temporary and subside with the completion of treatment. However, if these continue for a longer time, consult your doctor right away.
Furthermore, you should know that effect of Uridip 300 Tablet is Severe for pregnant women and Mild for women who are breastfeeding. Warnings related to Uridip 300 Tablet's effects on the liver, heart and kidney, if any, have been listed below.
The section on Uridip 300 Tablet contraindications lists all such conditions.
Besides this, Uridip 300 Tablet may also have severe interaction with some medicines. A complete list of these interactions is given below.
In addition to these precautions, you may also note that Uridip 300 Tablet is safe while driving, and is is addictive in nature.
Uridip 300 Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
| 2 - 12 years (Child) |
|
Based on research, the following side effects have been observed when Uridip 300 Tablet is used -
Mild
Is the use of Uridip 300 Tablet safe for pregnant women?
Uridip should not be taken during pregnancy, or should only be taken on the advice of a doctor as it may have severe side effects.
Is the use of Uridip 300 Tablet safe during breastfeeding?
Uridip may have very limited harmful effects for breastfeeding women.
What is the effect of Uridip 300 Tablet on the Kidneys?
Uridip can have moderate side effects on the kidney. If you notice any harmful effects, stop taking this drug right away. Consult your doctor before using this medicine again.
What is the effect of Uridip 300 Tablet on the Liver?
You may experience side effects on your liver after taking Uridip. If this happens, then discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Uridip 300 Tablet on the Heart?
Uridip has very mild side effects on the heart.
Uridip 300 Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Uridip 300 Tablet unless your doctor advises you to do so -
Is this Uridip 300 Tablet habit forming or addictive?
No, you will not get addicted to Uridip 300 Tablet.
Is it safe to drive or operate heavy machinery when consuming?
Uridip 300 Tablet will not make you feel sleepy or drowsy. So you drive or operate machinery safely.
Is it safe?
Uridip 300 Tablet is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
No, Uridip 300 Tablet is not used to treat mental disorders.
Interaction between Food and Uridip 300 Tablet
Some foods when eaten with Uridip 300 Tablet can alter the onset of actions. Discuss this with your doctor.
Interaction between Alcohol and Uridip 300 Tablet
Taking alcohol with Uridip 300 Tablet can be dangerous.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Zyloprim ® (allopurinol)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 216-217
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 125-127
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Zyloprim ® (allopurinol)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 216-217
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 125-127
